Tianjin Chase Sun Pharmaceutical Co.,Ltd

SZSE:300026 Rapport sur les actions

Capitalisation boursière : CN¥10.2b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Tianjin Chase Sun PharmaceuticalLtd Bilan de santé

Santé financière contrôle des critères 5/6

Tianjin Chase Sun PharmaceuticalLtd has a total shareholder equity of CN¥8.9B and total debt of CN¥1.5B, which brings its debt-to-equity ratio to 16.5%. Its total assets and total liabilities are CN¥12.0B and CN¥3.1B respectively. Tianjin Chase Sun PharmaceuticalLtd's EBIT is CN¥385.5M making its interest coverage ratio 10. It has cash and short-term investments of CN¥1.6B.

Informations clés

16.5%

Ratio d'endettement

CN¥1.48b

Dette

Ratio de couverture des intérêts10x
Argent liquideCN¥1.62b
Fonds propresCN¥8.92b
Total du passifCN¥3.08b
Total des actifsCN¥12.01b

Mises à jour récentes de la santé financière

Recent updates

These 4 Measures Indicate That Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Is Using Debt Reasonably Well

Aug 02
These 4 Measures Indicate That Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Is Using Debt Reasonably Well

There's No Escaping Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Muted Earnings

Jun 12
There's No Escaping Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Muted Earnings

Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Has Announced A Dividend Of CN¥0.03

May 22
Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Has Announced A Dividend Of CN¥0.03

This Broker Just Slashed Their Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) Earnings Forecasts

May 21
This Broker Just Slashed Their Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) Earnings Forecasts

Tianjin Chase Sun PharmaceuticalLtd's (SZSE:300026) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 04
Tianjin Chase Sun PharmaceuticalLtd's (SZSE:300026) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Analyse de la situation financière

Passif à court terme: 300026's short term assets (CN¥6.9B) exceed its short term liabilities (CN¥1.7B).

Passif à long terme: 300026's short term assets (CN¥6.9B) exceed its long term liabilities (CN¥1.4B).


Historique et analyse du ratio d'endettement

Niveau d'endettement: 300026 has more cash than its total debt.

Réduire la dette: 300026's debt to equity ratio has increased from 2.5% to 16.5% over the past 5 years.

Couverture de la dette: 300026's debt is well covered by operating cash flow (88.7%).

Couverture des intérêts: 300026's interest payments on its debt are well covered by EBIT (10x coverage).


Bilan


Découvrir des entreprises saines